ANALISIS IMPLEMENTASI CLINICAL PATHWAY SKIZOAFEKTIF TIPE MANIK DI RS JIWA GRHASIA

Background: Grhasia Mental Hospital implements the Manik
Type Schizoaffective clinical pathway but it is not efficient in
terms of treatment costs because the real cost of the hospital is
greater than the INA CBGs rate. The purpose of this study was to
analyze the implementation of the Manic Type Schizoaffective
clinical pathway on the length of stay and the cost of treatment.
Method: This type of research is quantitative, cross sectional with
a descriptive approach. The population of all hospitalized patients
with a diagnosis of Manic Type Schizoaffective. The number of
samples is 48 people. Data analysis using tableau.
Result and discussion: The average length of stay for Manic Type
Schizoaffective patients is 25 days, lower than the clinical
pathway prediction. There is use of drug variance outside the
formulary, namely sikzonoate/flufenazine inj and amitriptyline 25
mg tab. The cost of ward procedures contributed the most to the
higher cost of patient care. The total real cost is greater than the
acquisition of INA CBGs rates, clinical pathways.
Conclusions: The length of stay for Manic Type Schizoaffective
patients is lower than the clinical pathway prediction, which is 25
days. There are drug variances that are not in accordance with
the formulary, namely sikzonoate/flufenazine inj and amitriptyline
25 mg tab. The component of ward action costs contributed to the
highest patient care costs. The real cost of the hospital is greater
than the acquisition of INA CBGs claims.